kidney disease glp-1 news GLP-1s are back in the — but this is a conversation we've explored on our channel before. From weight loss to heart, kidney, liver, sleep and metabolic health, the science is New Hope for Kidney Disease:

Chromium: Helps regulate glucose metabolism and maintain healthy blood sugar levels already within normal ranges, aiding in metabolic balance

Glucagon-like peptide-1 (GLP-1)is an incretin hormonealso classified as a gut-derived peptidesecreted by intestinal L-cells in response to nutrient ingestion, particularly carbohydrates and fats

You may not edit, resell, or re-distribute.Please contact me if you have any problems

Beyond these frontrunners, the pipeline is expanding: Novo Nordisk filed for FDA approval of CagriSema in 2025, the first once-weekly combination of GLP1 and amylin analogue

Cardiologists also had a greater tendency than the other specialties to give the International Non-proprietary Name (INN) of new GLP-1s, rather than the brand name.